Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Kiniksa Pharmaceuticals GmbH c/o Kiniksa Pharmaceuticals Corp
October 16, 2025
Kiniksa Pharmaceuticals GmbH c/o Kiniksa Pharmaceuticals Corp
Orphan Drug Designation
FDA orphan drug designation: treatment of pericarditis
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
